{"disease":{"id":"myeloid-or-lymphoid-neoplasms-mln","name":"myeloid or lymphoid neoplasms mln"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04189445","title":"Futibatinib in Patients With Specific FGFR Aberrations","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":115,"lead_sponsor_name":"Taiho Oncology, Inc.","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}